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Abstract Despite widespread use and benefit, there are
growing concerns regarding hazards of second-generation
anticoagulant rodenticides to non-target wildlife which
may result in expanded use of first-generation compounds,
including chlorophacinone (CPN). The toxicity of CPN
over a 7-day exposure period was investigated in American
kestrels (Falco sparverius) fed either rat tissue mechani-
cally-amended with CPN, tissue from rats fed Rozol bait
(biologically-incorporated CPN), or control diets (tissue
from untreated rats or commercial bird of prey diet)
ad libitum. Nominal CPN concentrations in the formulated
diets were 0.15, 0.75 and 1.5 lg/g food wet weight, and
measured concentrations averaged 94 % of target values.
Kestrel food consumption was similar among groups and
body weight varied by less than 6 %. Overt signs of
intoxication, liver CPN residues, and changes in pro-
thrombin time (PT), Russell’s viper venom time (RVVT)
and hematocrit, were generally dose-dependent. Histolog-
ical evidence of hemorrhage was present at all CPN dose
levels, and most frequently observed in pectoral muscle
and heart. There were no apparent differences in toxicity
between mechanically-amended and biologically-incorpo-
rated CPN diet formulations. Dietary-based toxicity refer-
ence values at which clotting times were prolonged in
50 % of the kestrels were 79.2 lg CPN consumed/kg body
weight-day for PT and 39.1 lg/kg body weight-day for
RVVT. Based upon daily food consumption of kestrels and
previously reported CPN concentrations found in small
mammals following field baiting trials, these toxicity ref-
erence values might be exceeded by free-ranging raptors
consuming such exposed prey. Tissue-based toxicity ref-
erence values for coagulopathy in 50 % of exposed birds
were 0.107 lg CPN/g liver wet weight for PT and
0.076 lg/g liver for RVVT, and are below the range of
residue levels reported in raptor mortality incidents
attributed to CPN exposure. Sublethal responses associated
with exposure to environmentally realistic concentrations
of CPN could compromise survival of free-ranging raptors,
and should be considered in weighing the costs and benefits
of anticoagulant rodenticide use in pest control and eradi-
cation programs.
Keywords American kestrel  Anticoagulant
rodenticide  Birds  Clotting time  Non-target effects 
Risk assessment  Secondary poisoning
Introduction
The control of commensal vertebrate pests in agricultural,
suburban and urban settings has been dependent on the use
of anticoagulant rodenticides (ARs) for over 50 years.
Second-generation ARs (principally brodifacoum) have
played a central role in the eradication of invasive
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vertebrate pests in more than 700 island ecosystem resto-
ration projects during the past 30 years (Howald et al.
2007; Island Conservation 2012). Many reports describe
exposure and unintentional mortality of birds and mam-
mals (reviewed in Rattner et al. 2014b), although there is
no definitive evidence of large-scale population declines in
predatory and scavenging wildlife. It has been suggested
that ARs are an additional mortality factor affecting pop-
ulations that are experiencing critical limitations (Brakes
and Smith 2005). In a probabilistic assessment of 270
raptors found dead, at least 11 % of the great horned owls
(Bubo virginianus) analyzed were at risk of being directly
killed by second-generation ARs (SGARs; bromadiolone,
brodifacoum, difethialone) (Thomas et al. 2011). In much
of North America, the recent restrictions placed on the use
of SGARs (Health Canada 2012; USEPA 2012), are likely
to result in expanded use of first-generation ARs (FGARs).
In Europe SGARs continue to be the mainstay of rodent
control (reviewed in Rattner et al. 2014b).
Chlorophacinone (CPN) is a FGAR that has been used
worldwide for the control of commensal rodents, princi-
pally in agricultural and urban settings. It has been found in
liver tissue of non-target birds in various monitoring and
forensic investigations (Berny et al. 1997; Stone et al.
2003; Albert et al. 2010; Hughes et al. 2013; Vyas et al.
2013). There have been some secondary exposure incidents
in which the death of raptors (bald eagle Haliaeetus leu-
cocephalus; barn owl Tyto alba; ferruginous hawk Buteo
regalis; great horned owl) was attributed to CPN exposure
(Berny et al. 1997; USEPA 2011a, 2012; USFWS 2012).
Acute oral and short-term dietary toxicity studies in
Northern bobwhite (Colinus virginianus) in support of
CPN registration categorize this FGAR as being moder-
ately to highly toxic to birds (USEPA 2011a). Small-scale
studies with captive raptors fed CPN-exposed rodents have
described sublethal effects including hemorrhage, pro-
longed clotting time (coagulopathy), and other signs of
intoxication, but not mortality (Mendenhall and Pank 1980;
Radvanyi et al. 1988; Riedel et al. 1988; Askham and
Poche´ 1992; Salim et al. 2014). In these studies, both
Mendenhall and Pank (1980) and Salim et al. (2014)
attempted to estimate CPN exposure of barn owls fed
poisoned rats (Rattus norvegicus, R. rattus and R. tioma-
nicus) based on uneaten rodent remains and analyses of
excrement and castings. However, actual CPN concentra-
tion in poisoned rats was not quantified, and thus dietary
dose was a rough approximation at best. Remarkably, none
of these studies quantified CPN residues in liver, the
principal tissue used in AR forensic investigations in
wildlife and the major site of vitamin K recycling needed
for clotting factor carboxylation in hemostasis. Data on
dose and tissue residues are necessary in the development
of toxicity thresholds for adverse effects and to assess risk.
In the present study, we examined the toxicity of CPN in
American kestrels (Falco sparverius), a species often
selected as a model for raptorial birds (reviewed in Bardo
and Bird 2009), and recently found to be considerably more
sensitive to the FGAR diphacinone than traditionally tested
avian wildlife species (Northern bobwhite; mallards, Anas
platyrhynchos) (Rattner et al. 2011, 2012a, b). Graded
doses of CPN that had either been mechanically-amended
into rat tissue or biologically-incorporated into rat tissue
were fed to kestrels, and measurements of food intake and
tissue CPN residues were used to generate toxicity refer-
ence values for coagulopathy and examine thresholds for
other toxicological effects. The inclusion of two dietary
forms of CPN (i.e., mechanically-amended and biologi-
cally-incorporated) was undertaken to address potential
toxicological effects related to the presence of metabolites
and differences in bioavailability. With the likelihood that
FGAR use will continue, and perhaps even increase in the
near future, these and other data were incorporated into
assessments to more completely evaluate the risk of CPN
to predatory birds.
Materials and methods
Animals
Procedures involving animals were reviewed and approved
by the Institutional Animal Care and Use Committees of
the Patuxent Wildlife Research Center and the National
Wildlife Research Center. Adult 2- to 3-year old American
kestrels, propagated from the colony at Patuxent (Porter
and Wiemeyer 1970), were transferred from flight pens to
small cages (1.2 m long 9 0.8 m wide 9 0.6 m high) with
a shade roof, perches, food tray and water bowl. Only male
birds were used, due in part to their availability from the
colony and potentially confounding effects of egg-laying in
reproductively active females. Individually housed kestrels
(n = 40) were acclimated to pens for several weeks
(March and April 2013), and were fed dead chicks (Gallus
domesticus) or mice (Mus musculus; Charles River Labo-
ratories, Germantown, MD fed Purina 5L79 rodent chow
containing 3.4 ppm dry weight vitamin K). Two weeks
prior to the exposure trial, a 0.9 ml jugular venipuncture
sample was collected into 0.1 ml of 3.2 % sodium citrate
(Sigma-Aldrich, St. Louis, MO) from each bird. Microhe-
matocrit was determined, and the remainder of each blood
sample was centrifuged at 20009g for 5 min. Citrated
plasma was harvested and divided among 3 cryovials
stored at -80 C for subsequent determination of baseline
clotting time. Kestrels were then fed Classic Bird of Prey
diet (Nebraska Brand, North Platte, NE containing
2.63 ppm dry weight vitamin K) supplemented with
Chlorophacinone and American kestrels 721
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Vionate (Gimborn US, Atlanta, GA) for 11 days, after
which 35 birds were shifted to a diet of ground rat tissue
(see section on diet preparation) and 5 were maintained on
Classic Bird of Prey diet. The CPN toxicity study was
conducted between April 10 and 18, 2013 (ambient tem-
perature: 6.7–32.2 C), with the initial body weight
(mean ± SD) of kestrels being 104.0 ± 7.23 g.
Commercially available adult SAS Sprague–Dawley
outbred rats (Rattus norvegicus, n = 63 males and 63
females weighing 220–225 g; Charles River Laboratories,
Portage, MI) were used to prepare test diets for the kestrels.
Rats were group housed (n = 7–15, segregated by sex) in
large tanks (size range: 89 cm long 9 57 cm wide 9
58 cm high to 179 cm long 9 64 cm wide 9 61 cm high),
and provided food (Purina 5001 laboratory rodent diet
containing 1.3 ppm dry weight vitamin K) and water
ad libitum for a 1-week acclimation period.
Preparation of diets
Several diets were prepared for the CPN feeding trial. The
food for one control group consisted of commercially
available Classic Bird of Prey diet formed into
25.0 ± 0.1 g wet weight meatballs. The diet of a second
control group was tissue from untreated laboratory rats
euthanized with carbon dioxide. Briefly, fur, paws, tail,
gastrointestinal tract and skull were removed from car-
casses, and the remaining tissue was ground, forced
through a 3/16 inch extrusion plate and drained of excess
fluid using cheese cloth. This ground tissue (hereafter RT)
was amended with 15 ml vegetable oil/kg RT and formed
into 18.0 ± 0.1 g wet weight meatballs.
Three diets containing biologically-incorporated CPN
were prepared from rats (n = 35, mixed sexes) that had
been provided no choice ad libitum access to Rozol bait
(0.005 % CPN; Liphatech, Inc., Milwaukee, WI) for
3 days, and then euthanized. Ground tissue from CPN-fed
rats (fur, paws, tail, gastrointestinal tract and skull
removed) was chemically analyzed by reversed phase ion-
paired high-performance liquid chromatography (methods
described below) and found to contain about 1.5 lg CPN/g
wet weight. This tissue was mixed with varying quantities
of untreated RT to yield nominal concentrations of 0.15
and 0.75 lg CPN/g. Each of these diets was amended with
15 ml vegetable oil/kg tissue to maintain constant caloric
content used in the mechanically-amended diets, and then
formed into 18.0 ± 0.1 g wet weight meatballs.
Based upon concentrations used for the biologically-
incorporated CPN diets, three concentration-matched
mechanically-amended CPN diets were prepared from RT.
Neat CPN was dissolved in acetone, and then added to
vegetable oil (1:20). Varying quantities of this solution
were mixed into RT and additional vegetable oil was added
to maintain constant caloric content (total of 15 ml/kg RT).
Nominal CPN concentrations in these diets were 0.15, 0.75
and 1.5 lg/g RT wet weight, and 18.0 ± 0.1 g wet weight
meatballs were formed for use in the feeding trial.
The 2 control diets, 3 mechanically-amended CPN diets,
and 3 biologically-incorporated CPN diets were supple-
mented with Vionate and meatballs were stored frozen at
-10 C. Moisture content (mean ± SD) of the Classic
Bird of Prey control diet, RT control diet, 3 mechanically-
amended CPN diets, and the 3 biologically-incorporated
CPN diets were 63.0 ± 1.1, 70.1 ± 0.5, 69.0 ± 0.4 and
69.0 ± 0.9 %, respectively.
Chlorophacinone toxicity trial in American kestrels
One control group (n = 5 kestrels) was fed Classic Bird of
Prey meatballs throughout the course of the study, and
another control group (n = 5) was fed untreated RT
meatballs for 3 days prior to the study and also during the
course of the 7-day toxicity trial. These two control diets
were used to determine if there were any differences in
feeding Classic Bird of Prey (two 25 g meatballs/day) or
RT (two 18 g meatballs/day) on measurement endpoints.
Kestrels in the six CPN treatment groups (n = 5/group)
were fed untreated RT meatballs for 3 days prior to the
study, and then received either mechanically-amended or
biologically-incorporated diets for the 7-day exposure
period. Birds were fed daily between 1200 and 1300 h, and
uneaten food scraps were collected from kraft paper-lined
pens the following day between 1000 and 1200 h. The
scraps for each kestrel during the exposure period were
pooled, weighed, stored frozen at -10 C, dried at 100 C
for 24 h and mathematically converted back to wet weight
as previously described (Rattner et al. 2012a). The differ-
ence between the meatballs provided and scraps collected
on a wet weight basis was defined as total food intake over
the 7-day exposure period, and thus total CPN exposure.
Kestrels were observed three times daily during the
toxicity trial, and were weighed and examined on days 0, 3
and 5 of the exposure trial. On day 7, each bird was
examined, weighed, bled, sacrificed using carbon dioxide,
and then necropsied. Only 3 of 5 controls were sacrificed in
the Classic Bird of Prey and in the RT control groups.
Based on evidence of hemorrhage in our previous studies,
portions of pectoral muscle, heart, liver, kidney and gas-
trointestinal tract were fixed in 10 % phosphate-buffered
formalin. The remaining portion of liver was frozen at
-80 C for residue analysis. Microhematocrit was deter-
mined and the remainder of each blood sample was cen-
trifuged, citrated plasma harvested, and various volumes
pipetted into cryotubes that were stored frozen at -80 C
for subsequent clotting time assays.
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Chlorophacinone purity and concentrations in diet
and liver
The purity of neat CPN (CAS# 3691-35-8) was determined
by reversed phase ion-paired high-performance liquid
chromatography (RP-HPLC) with UV detection at 285 nm,
using diphacinone as the internal standard, as previously
described (Rattner et al. 2011, 2012a). The purity of CPN
used in preparing mechanically-amended diets was found
to be 99.6 % (% w/w).
Mechanically-amended and biologically-incorporated
RT diets were homogenized, solvent extracted, purified
using solid phase extraction cartridges, and CPN quantified
by RP-HPLC (Rattner et al. 2012a). Recovery of CPN from
spiked RT (mean ± SD, n = 6) was 82.9 ± 12.37 % at
0.198 lg/g and 89.4 ± 4.90 % at 1.95 lg/g wet weight.
Chlorophacinone at nominal concentrations of 0.15, 0.75
and 1.5 lg/g wet weight in the mechanically-amended
diets was quantified (n = 3/level), and averaged 86.5 ±
3.28, 89.6 ± 11.74, and 92.4 ± 9.67 % of target concen-
trations. Chlorophacinone at nominal concentrations of
0.15, 0.75 and 1.5 lg/g wet weight in the biologically-
incorporated diets was quantified (n = 3/level) and aver-
aged 98.2 ± 7.82, 100.1 ± 3.59, and 97.1 ± 6.20 % of
target concentrations.
Liver samples of treated kestrels were analyzed for CPN
as previously described in raptors (Rattner et al. 2011,
2012a). Recovery of CPN from spiked liver samples
(n = 4/level) averaged 71.3 ± 13.76 % at 0.46 lg/g and
91.9 ± 6.45 % at 4.30 lg/g wet weight. The method limit
of detection and method limit of quantification for liver
tissue was 0.049 and 0.16 lg/g wet weight, respectively.
Clotting time assays
Anticoagulant rodenticides inhibit vitamin K epoxide
reductase that is required for the formation of vitamin K
hydroquinone, the biologically active form of vitamin K
required for c-glutamyl carboxylation of clotting factors II,
VII, IX and X (Rattner et al. 2014b). Prothrombin time
(PT) and Russell’s viper venom time (RVVT) of citrated
plasma samples were used to examine CPN effects on post-
translational processing and activation of clotting factors.
The conduct of these assays in citrated plasma from raptors
has been described in detail (Rattner et al. 2011, 2012a,
2014a). The coefficient of variations (CVs) of duplicate
determinations (mean ± SD) of the baseline PT and RVVT
samples were 5.6 ± 4.30 and 1.2 ± 1.32 %, and for
exposure trial PT and RVVT samples, the CVs were
4.5 ± 5.56 and 2.4 ± 2.38 %. Thrombin clotting time
(TCT) was used as an indicator of fibrinogen concentration
in plasma. Fibrinogen deficiency resulting from improper
sample collection can prolong clotting time, and in
rodenticide toxicity studies it is important to verify that its
concentration is adequate to promote clot formation
(Rattner et al. 2010). Baseline fibrinogen concentration was
69.1 ± 19.2 mg/dL, with a CV of 1.6 ± 1.49 %, and
fibrinogen concentration for exposure trial samples was
85.6 ± 42.9 mg/dL, with a CV of 1.8 ± 2.66 %.
Histopathology
Formalin-fixed tissues were processed and embedded in
paraffin (American HistoLabs, Gaithersburg, MD) using
standard procedures (Luna 1968). Tissues were sectioned
at approximately 4 lm, mounted on slides, and stained
with Carazzi’s hematoxylin and eosin. Histologic evalua-
tion was performed blind with no a priori determined cri-
teria using the animal to animal technique with a
subsequent re-evaluation. Severity was scored on a semi-
quantitative 0–4 scale (none, minimal, mild, moderate,
severe, respectively).
Statistical methods
Measurement endpoints (body weight change, liver weight,
liver to body weight ratio, food consumption, hematocrit,
PT, RVVT, TCT, CPN consumption and liver residues)
were tested for homogeneity of variance and normality
(SAS version 9.3, SAS Institute, Carey, NC). Liver samples
with CPN residue levels that were \MLOD (n = 3 of 30)
were assigned a value of one-half the MLOD (USEPA
2000). Measurement endpoints (excluding CPN consump-
tion and liver residues) were first compared between con-
trol groups (i.e., Classic Bird of Prey diet and RT diet)
using Student’s t tests, and because they did not differ
(p = 0.16–0.98), they were combined into a single control
group. Subsequently, measurement endpoints were com-
pared among all groups by one-way analysis of variance
(mixed model) and Tukey’s HSD test. Body weight change
(days 3, 5 and 7) relative to initial day 0 weight (weight
change/100 g body weight) was evaluated over time using
a repeated measures analysis of variance. A suspect control
RVVT value, exceeding pre-study and control values by
more than 5 standard deviations, was confirmed as an
outlier using Grubb’s test and excluded from the data set
(Motulsky 2010). Liver CPN concentrations of the 6
treatment groups were tested using the aforementioned
parametric methods and simple linear regression, assigning
a value of one-half the MLOD to 3 of 30 samples for which
CPN was not detected.
The quantity of ingested CPN and the concentration of
CPN in liver of kestrels with prolonged clotting time were
used to derive dietary-based and tissue-based toxicity ref-
erence values (Filipsson et al. 2003; USEPA 2011b).
Response parameters included estimated CPN consumption/
Chlorophacinone and American kestrels 723
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kg body weight-day (arithmetic mean of each group) and
CPN residue in liver (geometric mean of each group) com-
pared to clotting time (dichotomous: number of kestrels in
each treatment group exceeding mean baseline clotting time
by[2 standard deviations). Using this dose–response curve,
benchmark doses at the 10, 50 and 90 % effect levels
(BMD10, BMD50 and BMD90) and benchmark dose lows
(BMDL, lower bound of the 95 % CI at these response
levels) were calculated using gamma, multi-stage, Weibull,
quantal-linear, logistic, log-logistic, probit and log-probit
models. Akaike’s Information Criterion and p values were
used to select the most appropriate model for these data.
Results
Chlorophacinone exposure and toxicity
Daily food consumption, expressed on a dry weight or wet
weight basis as grams consumed per kilogram kestrel, did
not differ among groups (Table 1). Daily food consump-
tion and measured quantities of CPN in diets were used to
estimate exposure. Chlorophacinone consumed by the 6
treatment groups ranged from 30.7 to 354.1 lg/kg body
weight-day (Table 1) and the estimated 7-day cumulative
dose ranged from 215 to 2,478 lg/kg body weight. Sta-
tistically significant differences (p \ 0.05) in exposure
were apparent among dose levels, but were comparable for
both the mechanically-amended and biologically-incorpo-
rated diets (Table 1). Chlorophacinone was detected in
liver of 3 of 5 kestrels fed the mechanically-amended
0.15 lg/g diet, 4 of 5 individuals receiving the biologi-
cally–incorporated 0.15 lg/g diet, and present in all birds
fed diets containing 0.75 or 1.5 lg/g (Table 1). While
residues seemed to be greater in both the 0.75 or 1.5 lg/g
groups compared to the lower dietary dose groups, a dif-
ference in residue concentrations was only significant
(p \ 0.05) compared to kestrels fed the biologically-
incorporated 1.5 lg/g diet. However, a simple linear
regression revealed that the cumulative dietary dose per
bird was associated with lg CPN per g liver after the 7-day
exposure period (p \ 0.001, adjusted R2 = 0.31, n = 30)
(Supplement S1).
All kestrels survived the 7-day feeding trial, and very
few exhibited overt signs of intoxication or macroscopic
evidence of hemorrhage at necropsy. A kestrel receiving
mechanically-amended CPN at a dose of 0.15 lg/g diet
appeared poorly preened between days 3 and 7 and its liver
appeared pale at necropsy. In the mechanically-amended
1.5 lg/g group, one kestrel exhibited some frank blood on
its feathers when captured on day 7, and two others
appeared to have pale viscera at necropsy. In the biologi-
cally-incorporated 1.5 lg/g group, one kestrel was T
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bleeding from its nares on day 7, and had pale viscera and a
swollen liver at necropsy, and another kestrel had a bruise
on the featherless tract of its neck (Fig. 1, compare a and
b). The repeated measures ANOVA detected a treatment
effect on body weight change (p \ 0.05), however, average
body weight change fluctuated by\6 % and did not vary in
a dose-dependent manner. On average, kestrels receiving
biologically-incorporated CPN at 1.5 lg/g diet gained the
most weight. For illustrative purposes, body weight change
after the 7-day exposure period (Dg/100 g initial body
weight) is presented in Table 2. Liver weight (range of
means: 2.01–2.37 g) and liver to body weight ratio (range
of means: 1.90–2.18 g/100 g body weight) did not differ
among groups (p [ 0.15).
Microscopic evidence of mild to moderate hemorrhage
was apparent in various tissues of kestrels fed either
3.0 cm3.0 cm
50 µm 
50 µm 50 µm 
100 µm 
(a) (b)
(c) (d)
(e) (f)
Fig. 1 a Featherless tract along neck of control America kestrel;
b bruising of featherless tract of a kestrel fed rat tissue containing
biologically-incorporated CPN at 1.5 lg/g wet weight diet; c moderate
perivascular hemorrhage in pectoral muscle of kestrel fed rat tissue
mechanically-amended with CPN at 0.15 lg/g; d tubular disruption
and multifocal hemorrhage in kidney of kestrel fed rat tissue
mechanically-amended with CPN at 0.75 lg/g; e mild hemorrhage
in liver of kestrel fed rat tissue containing biologically-incorporated
CPN at 1.5 lg/g; f focally extensive area of left ventricular
subepicardial hemorrhage of kestrel fed rat tissue mechanically-
amended with CPN at 1.5 lg/g
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mechanically-amended or biologically-incorporated CPN
diets, but not in controls (Table 2; Fig. 1c–f). Prevalence
did not appear to be dose-related, although this might be a
function of examining only a few sections in a portion of
each tissue. Incidental findings, with no evidence of clini-
cal disease, included mild inflammation in the pectoral
muscle, kidney, liver and heart, mild necrosis in the kidney
and heart, lymphoid aggregates in the kidney and liver,
vacuolation in tunica media and adventitia of arteries in the
pectoral muscle, kidney, heart, and intestine, and the pre-
sence of sarcocysts in pectoral muscle and heart of one-
third of the birds. In addition, there were several organ
specific changes including mild degeneration and regen-
eration of pectoral muscle, sloughed cells in tubular lumina
of the kidney, scattered mineralization in the kidney,
eosinophilic lace-like fibers or clear variably-sized round
vacuoles (glycogen, lipid) in the cytoplasm of hepatocytes,
pigmented macrophage aggregates in the liver, Kupffer
cells with golden brown to orange intracytoplasmic pig-
ment, thickening of the tunica media of portal arteries in
the liver, and mineralization of valves and blood vessels in
the heart.
Although hematocrit appeared to be slightly depressed
in kestrels fed CPN at 1.5 lg/g (Table 2), there were no
statistically significant differences among groups
(p [ 0.25). However, inspection of these data revealed that
1 of 5 individuals in the mechanically-amended 1.5 lg/g
group had a hematocrit of \30, and was thus classified as
anemic (Goodwin et al. 1992). Likewise, in the biologi-
cally-incorporated 1.5 lg/g group, 1 of 5 individuals was
anemic, and two other kestrels were close to being cate-
gorized as anemic.
Baseline PT and RVVT values (mean ± SD) were
12.02 ± 2.03 seconds (s) and 18.13 ± 2.42 s, respec-
tively. Both PT and RVVT of kestrels fed 0.75 and 1.5 lg/
g CPN diets for 7 days were prolonged (p \ 0.05) as much
as sevenfold when compared to clotting times of the
0.15 lg/g and control groups (Fig. 2). Notably, RVVT for
1 of 5 kestrels in the mechanically-amended 0.15 lg/g
group, and 2 of 5 kestrels in the biologically-incorporated
0.15 lg/g group, exceeded the mean baseline clotting time
value by more than two standard deviations. Mechanically-
amended and biologically-incorporated diet formulations
had similar effects on clotting time. Fibrinogen concen-
tration (insensitive to direct effects of ARs on vitamin K
epoxide reductase) exceeded the mean baseline value
(69.1 ± 19.2 mg/dL) by [2 standard deviations in 3 of 5
kestrels in both mechanically-amended and biologically-
incorporated 1.5 lg/g groups. However, this apparent dif-
ference in fibrinogen concentration was only statistically
significant (p \ 0.05) between the biologically-incorpo-
rated 1.5 lg/g group and controls at the end of the feeding
trial (Table 2).
Dietary- and tissue-based toxicity reference values
Using daily CPN consumption and the fraction of birds in
each group with clotting time exceeding baseline by 2
standard deviations yielded estimates of dietary-based
toxicity reference values. The dose–response curve for PT
was very steep (best fit: log-logistic model), such that PT
was not affected at the low CPN dietary dose, while all
kestrels exceeded baseline values at both the intermediate
and high CPN doses. The BMD10, BMD50 and BMD90,
and corresponding parenthetical BMDLs, for PT were
estimated to be 70.1 (32.5), 79.2 (39.6) and 89.4 (44.7) lg
CPN consumed/kg body weight-day, respectively (Fig. 3a).
The dose–response curve for RVVT was also steep (best
fit: logistic model), but several kestrels in the 0.15 lg/g
groups exceeded baseline clotting time values. The
BMD10, BMD50 and BMD90, and BMDLs for RVVT
were estimated to be 26.4 (12.6), 39.1 (32.6) and 51.9
(39.5) lg CPN consumed/kg body weight-day, respectively
(Fig. 3b).
Tissue-based toxicity reference values were estimated
using the geometric mean CPN concentration in liver for
each group and the fraction of birds with clotting time
exceeding the baseline mean by 2 standard deviations. The
dose–response curve for PT was steep (best fit: log probit
model). Prothrombin time was not affected at the low CPN
residue concentrations, while nearly all birds exceeded
baseline PT values at the intermediate and high liver res-
idue concentrations. The BMD10, BMD50 and BMD90
and corresponding BMDLs for PT were estimated to be
0.099 (0.064), 0.107 (0.074) and 0.114 (0.079) lg CPN/g
liver wet weight, respectively (Fig. 4a). The dose–
response curve for RVVT was also steep (best fit: probit
model), with several kestrels in the 0.15 lg/g groups
exceeding baseline clotting time values. The BMD10,
BMD50 and BMD90, and corresponding BMDLs, for
RVVT were estimated to be 0.048 (0.021), 0.076 (0.061)
and 0.105 (0.076) lg CPN/g liver wet weight, respectively
(Fig. 4b).
Discussion
Chlorophacinone evoked overt signs of intoxication and
histopathological lesions, and impaired blood clotting in
American kestrels—effects that are consistent with the
mechanism of action of ARs (Rattner et al. 2014b). In
contrast to previous CPN toxicity studies in raptors
(Mendenhall and Pank 1980; Radvanyi et al. 1988; Riedel
et al. 1988; Askham and Poche´ 1992), both the concen-
tration of CPN in food and the quantity of food consumed
by birds were measured to estimate the daily dose. Using
data from the present study, a 100 g adult kestrel ingested
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on average 7.84 g of food on a dry weight basis per day
(Table 1, average across groups), which falls in the range
of values (5.51–7.99 g dry weight per day) reported or
estimated (converting wet to dry weight using 67.8 %
average moisture content of food from the present study)
for captive kestrels (body weight: 91–113 g) fed lean beef,
venison or mice (Wing and Wing 1939; Craighead and
Craighead 1956; Duke et al. 1976). It is noteworthy that
these values are considerably lower than the bioenergetic
estimate (Nagy 1987) of 13 g dry weight per day for a 100
gram free-ranging kestrel that must forage naturally.
Food consumption of kestrels did not differ among con-
trol and treatment groups, and thus, exposure was propor-
tional to CPN concentration in the diet. Because dietary
CPN levels were a function of carcass residues of rats fed
Rozol bait for 3 days, it is believed that the concentrations
(range: 0.13–1.46 lg/g wet weight food) are environmen-
tally realistic. This is substantiated by observations in Bel-
ding’s ground squirrels (Spermophilus beldingi), pocket
gophers (Thomomys bottae) and voles (Microtus spp.) fol-
lowing field baiting trials; mean carcass CPN residues (liver,
head, pelt and appendages removed) ranged from 0.131 to
1.59 lg/g wet weight (Primus et al. 2001; Ramey et al.
2007), which not only overlaps, but exceeds dietary con-
centrations employed in the present study.
Signs of toxicity
Short-term dietary CPN exposure of kestrels resulted in
external evidence of bleeding, bruising, anemia, or pale
viscera in half of the birds receiving a nominal concen-
tration of 1.5 lg/g diet, with microscopic evidence of
Fig. 2 a Prothrombin time and
b Russell’s viper venom time of
American kestrels fed control
diet (Classic Bird of Prey = X,
Rat tissue = •), or
mechanically-amended or
biologically-incorporated CPN
diets for 7 days (individual
values in seconds and
mean ± SD). Horizontal
shaded area is the range of
baseline values determined
2 weeks before the trial. Bars
with different letters are
significantly different
(p \ 0.05)
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hemorrhage apparent at even lower levels of exposure.
Accordingly, there may be toxicity (prolonged clotting
time, histological lesions) without overt signs of intoxica-
tion. These responses are the direct consequence of inhi-
bition of vitamin K epoxide reductase, and failure to form
active clotting factors necessary for hemostasis (Rattner
et al. 2014b). Using PT and RVVT as biomarkers, pro-
longed clotting time was readily apparent in kestrels
receiving CPN at doses of 0.75 and 1.5 lg/g diet. These
responses were quite similar to those observed in Eastern
screech-owls (Megascops asio) fed the closely-related
FGAR diphacinone at a slightly greater concentration
(2.15 lg CPN/g diet for 7 days) (Rattner et al. 2012a).
Notably, there was some evidence that fibrinogen con-
centration actually increased in kestrels receiving CPN at
1.5 lg/g diet. Similar findings (i.e., up-regulation of
fibrinogen) have been described in rats fed the SGAR
difenacoum, and was attributed to changes in factor X and
other vitamin K-dependent clotting factors through a
feedback mechanism (Kerins 1999).
The present study compared toxicological responses of
kestrels receiving mechanically-amended or biologically-
incorporated dietary formulations of CPN. Recently, three
hydroxylated CPN metabolites (two sites on a side chain,
one on an indandione phenyl ring) have been isolated in
liver tissue of AR-resistant and -susceptible rats in a
Fig. 3 Dose-response relation
of CPN consumed and clotting
time of American kestrels
(adapted in part from Rattner
et al. 2014c). a Using the
benchmark dose method,
dietary-based toxicity reference
values at which prothrombin
time exceeded 10, 50 and 90 %
of the test population by 2
standard deviations above
baseline mean (BMD10,
BMD50, BMD90) occurred at
70.1, 79.2 and 89.4 lg CPN
consumed/kg body weight-day.
b Dietary-based toxicity
reference values at which
Russell’s viper venom time
exceeded 10, 50 and 90 % of
the test population by 2 standard
deviations above baseline mean
occurred at 26.4, 39.1 and
51.9 lg CPN consumed/kg
body weight-day
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bioaccumulation study (Vein et al. 2013). It was suggested
that the side chain hydroxylated metabolites may even
retain some anticoagulant activity (Vein et al. 2013), which
incidentally, does not seem to be the case for hydroxylated
metabolites of the FGAR warfarin (Sutcliffe et al. 1987).
While not quantified in the biologically-incorporated CPN
diet, it is likely that the diet contained both CPN and
hydroxylated metabolites. However, there was no evidence
of a differential effect of dietary CPN formulation on overt
signs of intoxication, hematocrit or clotting time.
Although kestrels exhibited typical signs of AR toxicity
(e.g., bruising, frank bleeding, blood in droppings, pallor;
see Stone et al. 1999, Murray 2011, Rattner et al. 2014b),
none succumbed during the 7-day feeding trial. Notably,
kestrels have been fed CPN-poisoned mice for 21 days,
and while there was evidence of behavioral effects, and
hemorrhage at necropsy, none died during the trial
(Radvanyi et al. 1988). In other studies in which CPN-
poisoned rodents were fed to barn owls, a great horned owl,
Eurasian buzzards (Buteo buteo) and red-tailed hawks
(Buteo jamaicensis) for 7–10 days, no mortality was
observed (Mendenhall and Pank 1980; Riedel et al. 1988;
Askham and Poche´ 1992). Such tolerance observed in
captive birds may not be the case for free-ranging raptors,
Fig. 4 Dose–response relation
of hepatic CPN concentration
and clotting time of American
kestrels. a Using the benchmark
dose method, tissue-based
toxicity reference values at
which prothrombin time
exceeded 10, 50 and 90 % of
the test population by 2 standard
deviations above baseline mean
(BMD10, BMD50, BMD90)
occurred at 0.099, 0.106 and
0.114 lg/g liver wet weight.
b Tissue-based toxicity
reference values at which
RVVT in 10, 50 and 90 % of
the test population exceeded the
baseline mean by 2 standard
deviations occurred at 0.048,
0.076 and 0.105 lg/g liver wet
weight
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as documented in several mortality incident reports (Berny
et al. 1997; CAEPA 2013; USEPA 2011a, 2012; USFWS
2012). Our own studies suggest that raptors may recover in
a matter of days to weeks following withdrawal of expo-
sure to the closely-related FGAR diphacinone (Savarie
et al. 1979, Rattner et al. 2014a), although exposure to
SGARs may result in long lasting inhibition of vitamin K
epoxide reductase, potentially rendering animals highly
susceptible to subsequent AR exposure (Mosterd and
Thijssen 1991). It has been suggested that AR toxicity may
be affected by body condition, and exacerbated by other
environmental stressors (e.g., extreme weather, foraging
energetics), nutrition (e.g., vitamin K status, nutritional
quality of synthetic laboratory diets versus natural food),
disease, other contaminants (lead-induced anemia), and
blood loss during molt (Rattner et al. 2014b).
Chlorophacinone residues in liver
Following the 7-day exposure period, CPN residues in liver
tended to be related to dietary dose. There were no dif-
ferences in residue concentrations between corresponding
doses of the mechanically-amended and biologically-
incorporated diets, suggesting relatively similar CPN bio-
availability and accumulation for the two formulations.
The maximum CPN residue found in liver was less than
0.005 % of the ingested dose. Elimination rate of CPN has
yet to be studied in birds. In laboratory mice, the elimi-
nation of the indandione CPN is biphasic, with overall half-
life estimates of 35.4 days for liver and 11.7 days for blood
plasma, which is less than that of several coumarin-based
first- and second-generations ARs (Vandenbroucke et al.
2008). The comparatively short half-life of CPN may
account for its low detection frequency (Berny et al. 1997;
Stone et al. 1999, 2003; Albert et al. 2010; Murray 2011;
Hughes et al. 2013; Vyas et al. 2013) and low hepatic
concentrations in predatory bird mortality incidents (i.e.,
0.18–0.40 lg/g liver wet weight in barn owl, great horned
owl, red-tailed hawk, ferruginous hawk, and bald eagles,
with the exception of one eagle, Aquila sp. with 6.2 lg/g
liver; Berny et al. 1997; USEPA 2011a, 2012; USFWS
2012). Tissue concentrations of SGARs associated with
mortality of predatory birds have been suggested to be in
the range of 0.1–0.2 lg/g liver (Newton et al. 1999), and
perhaps even \0.1 lg/g (Thomas et al. 2011). Such diag-
nostic thresholds for mortality have yet to be established
for FGARs. Perhaps one complicating issue in diagnosis of
FGAR intoxication is that much of the residue might be
cleared before the exposed animal succumbs. Definitive
diagnoses of secondary poisoning in raptors attributable to
FGARs is quite low, and some investigators explicitly state
that FGAR-related mortality in non-target wildlife is less
likely to occur than with SGARs (e.g., Berny et al. 1997;
Stone et al. 2003; Shlosberg and Booth 2006; USEPA
2011a).
Risk assessment and application of toxicity reference
values
The hazard of CPN to non-target wildlife has recently been
evaluated using deterministic risk assessment methods that
depend heavily on the use of risk quotients. Based on
single-day acute oral and short-term dietary exposure
studies with Northern bobwhite, CPN is moderately to
highly toxic, but predicted to pose limited risk to non-target
birds consuming poisoned-prey (USEPA 2011a). However,
data from single-day acute oral toxicity studies are not
appropriate for evaluation of FGARs that require multiple
feedings to evoke toxicity (Vyas and Rattner 2012).
Nonetheless, both single-day acute oral and multi-day
short-term dietary exposure studies with captive kestrels
and Eastern screech-owls have demonstrated that raptors
are considerably more sensitive to the FGAR diphacinone
than traditional avian test species such as Northern bob-
white (Rattner 2011, 2012a, b). It is noteworthy that a
deterministic risk assessment predicted that CPN could
pose a significant hazard to birds directly consuming bait
(USEPA 2011a), and such effects have been documented in
California quail (Callipepla californica) and wild turkeys
(Meleagris gallopavo) (USEPA 2011a), and recently in a
western meadowlark (Sturnella neglecta) (Vyas et al.
2013).
In the present study, a range of daily dietary doses and
the fraction of individuals exhibiting prolonged clotting
times were used to generate dietary-based toxicity refer-
ence values. It was estimated that half of the individuals
would exhibit prolonged PT at a daily dose of 79.2 lg/kg
body weight and prolonged RVVT at a daily dose of
39.1 lg/kg body weight, which is in agreement with values
in a preliminary report (Rattner et al. 2014c). Using a 100 g
kestrel as a model for raptors (Bardo and Bird 2009), these
PT and RVVT effect thresholds would correspond to
consumption of about 7.9 and 3.9 lg/bird-day, respec-
tively. As described above, mean carcass concentrations of
CPN reported for 3 species of small mammals following
field baiting trials ranged from 0.131 to 1.59 lg/g wet
weight (Primus et al. 2001; Ramey et al. 2007). Applying
the average moisture content estimate (i.e., 67.8 %) and the
derived wet to dry weight conversion factor (i.e., 3.10)
from the present study, these small mammal carcass CPN
values would correspond to approximately 0.406–4.93 lg/
g on a dry weight basis. Based upon daily food consump-
tion for captive kestrels (*6.92 g dry weight, average
from Wing and Wing 1939; Craighead and Craighead
1956; Duke et al. 1976; and present study), the quantity of
CPN ingested by birds feeding exclusively on poisoned
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prey would range from 2.81 to 34.1 lg/day, which
encompasses the thresholds associated with coagulopathy
(7.9 and 3.9 lg CPN/bird-day for PT and RVVT) in 50 %
of exposed individuals. Using food consumption estimates
for a free-ranging kestrel (13 g dry weight per day; *1.65
times greater than consumption for captive kestrels in the
present study), the quantity of CPN ingested daily by birds
feeding exclusively on poisoned prey would range from
5.28 to 64.1 lg/day, and the risk of coagulopathy might be
greater. While prey availability, daily consumption, CPN
residues and even unabsorbed AR-containing bait in the
gut of target species are likely to vary considerably, these
data suggest that ingestion of CPN-exposed prey by raptors
for an extended period (e.g., 1-week or longer) could result
in coagulopathy.
Our findings demonstrate that short-term dietary exposure
to CPN resulting in liver residue concentrations of approx-
imately 0.107 lg/g wet weight was associated with pro-
longed PT in 50 % of the exposed kestrels. Even lower CPN
residue levels (0.076 lg/g) resulted in prolonged RVVT in
half of the exposed kestrels. These tissue-based toxicity
reference values for coagulopathy are below liver CPN
concentrations reported in raptor mortality incidents
(0.18–6.2 lg CPN/g liver; Berny et al. 1997; USEPA 2010,
2011a; USFWS 2012). Furthermore, hepatic CPN concen-
trations are lower than reported for the FGAR diphacinone
in Eastern screech-owls (i.e., BMD50 for PT = 0.345 lg/g
liver wet weight; BMD50 for RVVT = 0.319 lg/g liver)
(Rattner et al. 2014a), which is consistent with the com-
paratively greater toxicity of CPN in short-term dietary
studies in Northern bobwhite and mallards (USEPA 2011a).
These toxicity reference values for coagulopathy fall in the
range of concentrations reported for dead raptors (i.e.,
0.1–0.4 lg/g liver) exhibiting signs of hemorrhage (Newton
et al. 1999; Stone et al. 1999, 2003; Albert et al. 2010).
While coagulopathy is a key event in the adverse outcome
pathway of ARs (Rattner et al. 2014b), fatal hemorrhage in
AR exposed animals seems to be a multi-causal phenome-
non (Kaukeinin 1982), and predicting overall consequences
is quite challenging (Rattner et al. 2014b).
Conclusions
Dietary exposure to environmentally realistic levels of
CPN evoke signs of toxicity in captive American kestrels
that are consistent with the cellular, organ, and whole
animal responses described in the adverse outcome path-
way for ARs in raptors (Rattner et al. 2014b). Registration
data, peer-reviewed published literature, and risk assess-
ments suggest that the FGAR CPN is less hazardous than
SGARs. However, a direct comparison of the toxicity of
various FGARs and SGARs using environmentally
relevant exposure scenarios has yet to be adequately
evaluated. The effects of intermittent FGAR exposure, and
sequential combinations of FGARs and SGARs on raptors
are unclear, and warrant investigation. The hazards of CPN
and the FGAR diphacinone (Rattner et al. 2011, 2012a, b,
2014a) to non-target predatory birds may be greater than
previously perceived, and needs to be considered in
weighing the costs and benefits of AR use in pest control
and eradication programs.
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